Antibiofilm Activity against Multidrug-Resistant Pathogens
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiofilm Strategies".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 2049
Special Issue Editors
Interests: multidrug-resistant bacteria; bacterial biofilm; antimicrobial agents; essential oils; phytochemicals; bacteriophages; synergistic interactions; Acinetobacter baumannii
Interests: bacteriophages; antimicrobial agents; bacterial biofilm; multidrug-resistant bacteria; Pseudomonas aeruginosa; phage therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Ninety-nine percent of bacteria exist in the form of a biofilm, which represents an emerging problem in global public health, causing great concern to the population, health professionals and the scientific community. Microbial biofilms possess intrinsic resistance against conventional antibiotics and cleaning procedures, with the capability to firmly adhere to surfaces for persistent contamination. The biofilm matrix provides bacteria with additional resistance power, which enables them to tolerate harsh conditions and also resist antimicrobials, which can lead to the spread of infections such as multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria. Current conventional therapies are inadequate for the safe and effective treatment of biofilms, since high doses of antibiotics are required to eradicate biofilms, indicating that biofilm treatment needs new therapeutical strategies. These global issues strongly motivate researchers to develop novel methodologies to investigate the kinetics underlying biofilm formation, to understand the response of the biofilm to different chemical and physical treatments, and to identify biofilm-specific drugs with high-throughput screenings. This Special Issue seeks manuscript submissions that improve our understanding of the process of biofilm formation in general, novel strategies for its investigation, as well as efficient agents for its treatment. Submissions on the treatment and potential eradication of biofilms using alternative antimicrobial agents (alone and in synergistic combinations) and/or novel strategies for their investigation and combined treatment to reduce their transmission and spread are especially encouraged.
Dr. Verica Aleksic Sabo
Prof. Dr. Petar Knezevic
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biofilm
- microbial drug resistance
- antibiofilm agents
- antibiofilm strategies
- synergistic interactions
